arrow
Y

Yi Fang

guangzhou medical university
H指数:14
被引数:782

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a novel anti-TSLP bispecific antibody (GR2002) in healthy Chinese adults: a randomized, placebo-controlled phase 1 trial

安全性、耐受性、药代动力学、药效动力学和免疫原性:一项新型抗TSLP双特异性抗体(GR2002)在中国健康成人中的随机、安慰剂对照的1期临床试验

2026-01-080
OAAI
A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study Evaluating the Pharmacokinetics of Single-Dose Tapentadol Hydrochloride Intravenous Infusion and Tapentadol Hydrochloride Oral Tablets in Patients with Pain

一项多中心、随机、开放标签、活性对照、平行组研究,评估单剂量盐酸曲马多静脉输注和盐酸曲马多口服片剂在疼痛患者中的药代动力学。

2025-10-010
PRE
A Phase I, Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Etelcalcetide Administered Intravenously to Chinese Patients With Chronic Kidney Disease Undergoing Hemodialysis

一项I期,多剂量,随机,双盲,安慰剂对照研究,以评估静脉注射Etelcalcetide对接受血液透析的中国慢性肾脏疾病患者的药代动力学,安全性和耐受性

2021-11-010
OAAI